These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions. Zareba W Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515 [No Abstract] [Full Text] [Related]
25. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger? Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822 [No Abstract] [Full Text] [Related]
26. Cardioverter-defibrillator implantation to treat cardiac fibroma-induced ventricular tachycardia in a 70-year-old woman. Hakim FA; Pandit A; Mookadam F; Mamby S Tex Heart Inst J; 2014 Jun; 41(3):329-31. PubMed ID: 24955056 [TBL] [Abstract][Full Text] [Related]
27. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077 [TBL] [Abstract][Full Text] [Related]
28. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion. Duru F; Bauersfeld U; Candinas R Europace; 2001 Jan; 3(1):80-4. PubMed ID: 11271957 [TBL] [Abstract][Full Text] [Related]
29. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring. Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741 [TBL] [Abstract][Full Text] [Related]
30. Sudden Cardiac Death Despite a Functional Cardioverter-Defibrillator: The Case for Early and Aggressive Therapy for Ventricular Tachycardia in Selected Patients. Montgomery JA; Kanagasundram AN; Clair WK; Rottman JN; Crossley GH J Cardiovasc Electrophysiol; 2016 Jan; 27(1):120-4. PubMed ID: 26511459 [TBL] [Abstract][Full Text] [Related]
31. [Indications for implantable cardioverter-defibrillator]. Tebbenjohanns J; Niehaus M; Korte T Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558 [No Abstract] [Full Text] [Related]
32. Two tachycardias, wide and narrow-more than a coincidence? Back Sternick E; Bagchi A; Lokhandwala Y; Wellens HJ J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1553-1556. PubMed ID: 32275341 [No Abstract] [Full Text] [Related]
33. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization. Alexandre J; Saloux E; Lebon A; Dugué AE; Lemaitre A; Roule V; Labombarda F; Champ-Rigot L; Gomes S; Pellissier A; Scanu P; Milliez P Europace; 2014 Feb; 16(2):220-6. PubMed ID: 24186956 [TBL] [Abstract][Full Text] [Related]
34. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism? Vollmann D; Lüthje L; Zabel M Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370 [No Abstract] [Full Text] [Related]
35. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion. Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316 [TBL] [Abstract][Full Text] [Related]
36. Pacemapping guided by defibrillator electrograms for ventricular tachycardia ablation in a patient with ARVD/C. Fontenla A; Lozano Á; López-Gil M; Arribas F J Cardiovasc Electrophysiol; 2018 Feb; 29(2):336. PubMed ID: 29024127 [No Abstract] [Full Text] [Related]
37. Catecholaminergic polymorphic ventricular tachycardia detected by an implantable loop recorder in a child. Ergül Y; Kıplapınar N; Akdeniz C; Tuzcu V Turk Kardiyol Dern Ars; 2013 Jul; 41(5):436-9. PubMed ID: 23917010 [TBL] [Abstract][Full Text] [Related]
38. Ventricular Tachycardia in Fabry Disease Detected in a 50-Year-Old Woman during 14-Day Continuous Cardiac Monitoring. Silva-Gburek J; Rochford L; Hopkin R; Jefferies JL Tex Heart Inst J; 2016 Dec; 43(6):531-533. PubMed ID: 28100976 [TBL] [Abstract][Full Text] [Related]